NCT03003936

Brief Summary

The purpose of this investigation is to assess in a community-based cohort of late-night eaters the effect of coincident food intake and endogenous melatonin on glycemic control, and the putative interaction effect of melatonin receptor 1B (MTNR1B) genetic variation on this relationship. With the results from this study, the investigators expect to advance in the understanding of the role of endogenous melatonin on glucose metabolism in late night eaters and carriers of the MTNR1B risk allele, with potential implications on the guidelines to mitigate risk of type 2 diabetes in late night eaters and carriers of the MTNR1B risk allele.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 16, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 28, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

2.4 years

First QC Date

December 16, 2016

Last Update Submit

October 26, 2017

Conditions

Keywords

Glucose toleranceMTNR1BnutrigenomicsFood timing

Outcome Measures

Primary Outcomes (1)

  • Area Under the Curve (AUC) glucose

    Investigators will measure glucose levels for 120 minutes at day time and night time visits, and compare the results by genotype at selected loci.

    between 0-120 minutes, Visit 2 and 3

Secondary Outcomes (2)

  • Fasting glucose

    between 0-120 minutes, Visit 2 and 3

  • Saliva Melatonin

    between 0-120 minutes, Visit 2 and 3

Other Outcomes (6)

  • Sleep Duration

    total of 2 weeks between Visit 1 and 3

  • Light Exposure

    total of 2 weeks between Visit 1 and 3

  • Total Energy Intake

    total of 2 weeks between Visit 1 and 3

  • +3 more other outcomes

Study Arms (2)

Early Dinner Timing

EXPERIMENTAL

Test the lack of concurrence of meal timing with endogenous melatonin concentrations

Behavioral: Dinner timing

Late Dinner Timing

EXPERIMENTAL

Test the concurrence of meal timing with elevated endogenous melatonin concentrations

Behavioral: Dinner timing

Interventions

Dinner timingBEHAVIORAL

Glucose tolerance after a late diner (1 hour before habitual bedtime) differs from early dinner (4 hours before habitual bedtime) due to the concurrence of meal timing with different levels of endogenous melatonin. This effect can be different among risk allele carriers (G) or non-rick allele carriers (C) of the MTNR1B.

Early Dinner TimingLate Dinner Timing

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body Mass Index: \>19 kg/m2
  • Age: \>18 years of age
  • Caucasian

You may not qualify if:

  • Receiving treatment with thermogenic, lipogenic, or contraceptive drugs
  • Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis
  • Bulimia diagnosis, prone to binge eating
  • Undergoing treatment with anxiolytic or antidepressant drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Murcia

Murcia, 30100, Spain

Location

Related Publications (1)

  • Lopez-Minguez J, Saxena R, Bandin C, Scheer FA, Garaulet M. Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study. Clin Nutr. 2018 Aug;37(4):1133-1140. doi: 10.1016/j.clnu.2017.04.003. Epub 2017 Apr 10.

Study Officials

  • Marta Garaulet, PHD

    Universidad de Murcia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Proffesor

Study Record Dates

First Submitted

December 16, 2016

First Posted

December 28, 2016

Study Start

December 1, 2014

Primary Completion

May 1, 2017

Study Completion

June 1, 2017

Last Updated

October 27, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations